Management
Bridge’s management team combines strong complementary backgrounds in technology, finance, M&A, and international business development together with strong networks in both Israel and the Great Lakes Region. Avshalom Horan runs Bridge’s operation in Tel Aviv while Michael Goldberg oversees Bridge’s efforts in Cleveland, Ohio.
Advisory Board
Bridge’s advisory board provides the Fund with broad range of medical, business and investment expertise. Current board members include Dr. Steven Girouard, Senior Director, Emerging Technologies in the Corporate Office of Science and Technology at Johnson & Johnson, Kevin McGinty, Managing Director of Peppertree Capital Management, and Peppertree Partners, Dr. Jeffrey Ponsky, the Chairman of the Department of Surgery at University Hospitals of Cleveland, Bill Schecter, the Chairman Emeritus of National City Equity Partners and Baiju Shah, CEO of BioEnterprise Corporation.